DOCM
vs
S
Swiss Market Index
DOCM
Over the past 12 months, DOCM has underperformed Swiss Market Index, delivering a return of -29% compared to the Swiss Market Index's +13% growth.
Stocks Performance
DOCM vs Swiss Market Index
Performance Gap
DOCM vs Swiss Market Index
Performance By Year
DOCM vs Swiss Market Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
DocMorris AG
Glance View
DocMorris Ltd. engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. The company is headquartered in Frauenfeld, Thurgau and currently employs 2,283 full-time employees. The company went IPO on 2017-07-06. The firm focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The firm's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The firm operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.